CA-036: Pharmacoépidémiologie du diabète : usage des antidiabétiques à l'Institut National de Santé Publique de Côte d'Ivoire (résultats préliminaires)

Antidiabetics and antihypertensive medications use in Morocco: A pharmacoepidemiological descriptive study

“…In terms of antidiabetics, our findings pointed out the widespread use of the biguanides, both in monotherapy and in association with various antidiabetic agents, and defined the same epidemiological pattern in other developing African countries. 11 , 12 , 13 The national pharmaceutical market of antidiabetics progressed from ranging over six specialties (1991) to 16 specialties (2005) translating the huge demands for these agents, evolving from 1.9 to 14 DDD/1000 inhabitants/day (DDD = defined daily dose) from 1997 to 2014. 14 Analyses show that the national consumption of sulfonylureas and metformin have increased by four and 10 times respectively from 1997 to 2004.…”